antibacterial pharmaceutical composition on the basis of very u0446u0438u043au043bu043eu0434u0435u043au0441u0442u0440u0438u043du0430 containing an antibiotic from the group u0440u0438u0444u0430u043cu0438u0446u0438u043du043eu0432, its method of production and ways of l u0435u0447u0435u043du0438u044f

摘要

the invention relates to medicine and pharmacy, and to pharmaceutical compositions for the treatment of u043cu0438u043au043eu0431u0430u043au0442u0435u0440u0438u043eu0437u043eu0432 and u0433u0435u043bu0438u043au043eu0431u0430u043au0442u0435u0440u043du043eu0439 infectionon the basis of dispersed in the u0444u0430u0440u043cu0430u0446u0435u0432u0442u0438u0447u0435u0441u043au0438 acceptable medium very u0446u0438u043au043bu043eu0434u0435u043au0441u0442u0440u0438u043du0430 ranging from 100 to 1000 nm.containing u0442u0435u0440u0430u043fu0435u0432u0442u0438u0447u0435u0441u043au0438 effective number of u0434u0438u0441u043fu0435u0440u0433u0438u0440u043eu0432u0430u043du043du043eu0433u043e in an antibiotic from the group u0440u0438u0444u0430u043cu0438u0446u0438u043du043eu0432 (preferably u0440u0438u0444u0430u0431u0443u0442u0438u043du0430), as well as u0444u0430u0440u043cu0430u0446u0435u0432u0442u0438u0447u0435u0441 kee acceptable excipients.with the fact that they u043du0430u043du043eu0447u0430u0441u0442u0438u0446u044b contain polymer, method of obtaining (fusion) of the pharmaceutical composition.as well as treatments u043cu0438u043au043eu0431u0430u043au0442u0435u0440u0438u043eu0437u043eu0432 and u0433u0435u043bu0438u043au043eu0431u0430u043au0442u0435u0440u043du043eu0439 infection, including injecting, and / or u0432u043du0443u0442u0440u0438u043cu044bu0448u0435u0447u043du043eu0435,the introduction and / or oral administration in this patient the composition (in the form of a suspension in u0444u0430u0440u043cu0430u0446u0435u0432u0442u0438u0447u0435u0441u043au0438 acceptable medium) in u0442u0435u0440u0430u043fu0435u0432u0442u0438u0447u0435u0441u043au0438 u044du0444u0444u0435u043au0442u0438u0432u043d om number.a composition in accordance with the invention may be implemented as a u043bu0438u043eu0444u0438u043bu0438u0437u0430u0442u0430,fit (after dispersing in u0444u0430u0440u043cu0430u0446u0435u0432u0442u0438u0447u0435u0441u043au0438 acceptable medium) for intravenous or u0432u043du0443u0442u0440u0438u043cu044bu0448u0435u0447u043du043eu0433u043e of the patient, and in the form of powder.fit for production of solid oral pharmaceutical forms, and ensures the efficiency of not less than (and, in some cases, more) high.u0440u0438u0444u0430u0431u0443u0442u0438u043du0430 than traditional oral forms (capsules), and perfect existing traditional oral forms, and known u043du0430u043du043eu0441u043eu043cu0430u043bu044cu043du044bu0445 (call u043eu0438u0434u043du044bu0445) forms of the antibiotics.